- Report
- January 2023
- 32 Pages
United States
From €2643EUR$2,995USD£2,286GBP
- Report
- January 2023
- 32 Pages
United Kingdom
From €2643EUR$2,995USD£2,286GBP
- Report
- January 2023
- 32 Pages
Spain
From €2643EUR$2,995USD£2,286GBP
- Report
- January 2023
- 32 Pages
South Korea
From €2643EUR$2,995USD£2,286GBP
- Report
- January 2023
- 32 Pages
Russia
From €2643EUR$2,995USD£2,286GBP
- Report
- November 2024
- 147 Pages
Russia, India, China, ... Russia, India, China, Brazil
From €4408EUR$4,995USD£3,812GBP
- Report
- October 2024
- 51 Pages
Japan
From €4408EUR$4,995USD£3,812GBP
- Report
- June 2023
- 132 Pages
Global
From €838EUR$950USD£725GBP
- Book
- September 2021
- 1184 Pages
- Book
- November 2022
North America
- Book
- April 2022
- 560 Pages

Orthobiologics is a field of biotechnology that focuses on the development of products and treatments to improve musculoskeletal health. It includes the use of biological materials such as stem cells, growth factors, and proteins to repair, regenerate, and replace damaged or diseased tissues. Orthobiologics is used to treat a variety of musculoskeletal conditions, including fractures, tendon and ligament injuries, and degenerative joint diseases. It is also used to improve the healing of bone and soft tissue after surgery.
Orthobiologics is a rapidly growing field, with new products and treatments being developed to improve patient outcomes. It is becoming increasingly important in the treatment of musculoskeletal conditions, as it offers a more natural and less invasive approach than traditional treatments.
Some companies in the Orthobiologics market include Acelity, AlloSource, Arthrex, Bioventus, DePuy Synthes, Exactech, Integra LifeSciences, Medtronic, MiMedx, Orthofix, and Stryker. Show Less Read more